Trial Details
RECRUITINGBasic Information
| Clinical ID | c184 |
|---|---|
| Identifier | NCT07012395 |
| Trial Title | A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Inflammatory Bowel Diseases|Colitis|Colitis, Ulcerative |
| Interventions | DRUG: SPY001|DRUG: SPY002|DRUG: SPY003|OTHER: Placebo |
Participant Information
| Sponsor | Spyre Therapeutics, Inc. |
|---|---|
| City | Canoga Park |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-05-27 |
|---|---|
| Primary Completion Date | 2026-06 |
| Completion Date | 2028-03 |